FeBI Technologies featured in TRAM article

FeBI Technologies have been featured in a new article from the team at Translating Research At Melbourne.

In the realm of deep tech innovation, quantum technology has emerged as a strategic priority for research and development worldwide. At the forefront of this quantum revolution stands FeBI Technologies, a pioneering company leveraging novel quantum sensing technology to address a global health challenge affecting over 2 billion people: iron disorders.

The iron imperative

Iron-related health issues are alarmingly prevalent. Iron deficiency, the world’s most common nutritional problem, disproportionately affects women, with one in five impacted in Australia. Dr Nicole Jenkins, Co-Founder and CEO of FeBI Technologies, is a researcher focused on the influence of iron on the biology of ageing and neurodegeneration and is passionate about iron and iron status as a health marker.

Read the full article here.

Previous
Previous

FeBI CEO, Dr Nicole Jenkins, highlighted for International Women’s Day

Next
Next

FeBI Technologies industry partner on successful Quantum 2032 Challenge application